Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sequenom, a provider of genetic analysis products, has appointed Allan Bombard as its new chief medical officer. In this position, Dr Bombard will oversee Sequenom's clinical and medical affairs, including clinical strategy, operations and clinical advocacy.
Subscribe to our email newsletter
Before joining Sequenom, Dr Bombard was the CEO of Lenetix Medical Laboratory of Mineola, New York. Prior to joining Lenetix, Dr Bombard was chief medical officer of Sharp Mary Birch Hospital in San Diego.
Dr Bombard has received his BA degree from Colgate University, his doctor of medicine degree from the George Washington University School of Medicine and Health Sciences, and completed an MBA at the University of San Diego.
Harry Stylli, president and CEO of Sequenom, said: “Allan has played an instrumental role in the development of our noninvasive prenatal diagnostic division, including serving as the principal investigator in a screening study to clinically assess the company’s noninvasive prenatal diagnostic technology for the detection of Down syndrome from a maternal blood sample. We are very pleased to have his leadership and experience on a full-time basis, and we welcome him aboard.”